US Stock MarketDetailed Quotes

AVXL Anavex Life Sciences

Watchlist

7.335
+0.500+7.32%

Trading Nov 4 15:57 ET

621.98MMarket Cap-14382P/E (TTM)

Anavex Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Jun 30, 2024

(Q2)Mar 31, 2024

(Q1)Dec 31, 2023

(FY)Sep 30, 2023

(Q4)Sep 30, 2023

(Q3)Jun 30, 2023

(Q2)Mar 31, 2023

(Q1)Dec 31, 2022

(FY)Sep 30, 2022

(Q4)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

32.31%-5.18M

-37.31%-11.66M

-26.30%-7.32M

-14.63%-27.79M

-44.63%-5.85M

-8.50%-7.65M

11.94%-8.49M

-65.50%-5.79M

20.23%-24.24M

47.31%-4.04M

Net income from continuing operations

-8.28%-12.21M

19.54%-10.55M

33.53%-8.62M

0.99%-47.51M

29.00%-10.15M

8.79%-11.28M

-25.57%-13.11M

-19.20%-12.97M

-26.56%-47.98M

-21.95%-14.29M

Other non cash items

----

--845K

--0

----

Change In working capital

2,027.20%4.61M

-1,809.64%-3.76M

-153.63%-982K

-53.27%2.51M

-73.60%1.11M

-118.03%-239K

94.59%-197K

-47.27%1.83M

859.35%5.36M

371.26%4.2M

-Change in receivables

-19.71%2.07M

63.30%-236K

6.87%-840K

-91.86%484K

-116.13%-543K

2,931.29%2.57M

41.38%-643K

-123.96%-902K

238.65%5.94M

729.25%3.37M

-Change in prepaid assets

84.52%286K

-80.12%-589K

65.78%-103K

-30,000.00%-299K

61.99%174K

5,766.77%155K

-276.97%-327K

-1,249.11%-301K

-98.86%1K

210.01%107.41K

-Change in payables and accrued expense

176.03%2.26M

-479.95%-2.94M

-101.52%-39K

416.27%1.85M

102.65%1.48M

-309.84%-2.97M

131.45%773K

1,049.48%2.56M

-119.15%-584K

-52.13%729.84K

-Change in other working capital

----

--473K

--0

--473K

----

Cash from discontinued investing activities

Operating cash flow

32.31%-5.18M

-37.31%-11.66M

-26.30%-7.32M

-14.63%-27.79M

-44.63%-5.85M

-8.50%-7.65M

11.94%-8.49M

-65.50%-5.79M

20.23%-24.24M

47.31%-4.04M

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

-49.46%4.55M

-60.31%7.28M

-77.13%59K

39.29%29.65M

83,341.56%2.06M

30.28%9M

54.90%18.33M

-89.84%258K

-86.11%21.29M

-99.89%2.46K

Net common stock issuance

-51.89%4.11M

----

32.83%27.88M

41,554.98%1.19M

29.65%8.53M

----

-86.30%20.99M

1,022.83%2.85K

Proceeds from stock option exercised by employees

-5.33%444K

-45.30%99K

-77.13%59K

75.84%1.78M

456,942.11%868K

-8.62%469K

46.65%181K

-30.92%258K

-81.88%1.01M

-100.01%-190

Net other financing activities

----

87.26%-707K

98.87%-198

Cash from discontinued financing activities

Financing cash flow

-49.46%4.55M

-60.31%7.28M

-77.13%59K

39.29%29.65M

83,341.56%2.06M

30.28%9M

54.90%18.33M

-89.84%258K

-86.11%21.29M

-99.89%2.46K

Net cash flow

Beginning cash position

-9.18%139.39M

0.10%143.77M

1.25%151.02M

-1.94%149.16M

1.06%154.82M

0.08%153.47M

-4.98%143.62M

-1.94%149.16M

420.05%152.11M

-2.77%153.2M

Current changes in cash

-146.67%-630K

-144.48%-4.38M

-31.12%-7.26M

163.25%1.87M

6.15%-3.79M

1,042.71%1.35M

348.27%9.85M

-475.83%-5.54M

-102.40%-2.95M

25.87%-4.04M

End cash Position

-10.37%138.76M

-9.18%139.39M

0.10%143.77M

1.25%151.02M

1.06%154.82M

0.08%153.47M

-4.98%143.62M

-1.94%149.16M

Free cash flow

32.31%-5.18M

-37.31%-11.66M

-26.30%-7.32M

-14.63%-27.79M

-44.63%-5.85M

-8.50%-7.65M

11.94%-8.49M

-65.50%-5.79M

20.23%-24.24M

47.31%-4.04M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Jun 30, 2024	(Q2)Mar 31, 2024	(Q1)Dec 31, 2023	(FY)Sep 30, 2023	(Q4)Sep 30, 2023	(Q3)Jun 30, 2023	(Q2)Mar 31, 2023	(Q1)Dec 31, 2022	(FY)Sep 30, 2022	(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	32.31%-5.18M	-37.31%-11.66M	-26.30%-7.32M	-14.63%-27.79M	-44.63%-5.85M	-8.50%-7.65M	11.94%-8.49M	-65.50%-5.79M	20.23%-24.24M	47.31%-4.04M
Net income from continuing operations	-8.28%-12.21M	19.54%-10.55M	33.53%-8.62M	0.99%-47.51M	29.00%-10.15M	8.79%-11.28M	-25.57%-13.11M	-19.20%-12.97M	-26.56%-47.98M	-21.95%-14.29M
Other non cash items	----	----	----	--845K	--0	--0	----	----	----	----
Change In working capital	2,027.20%4.61M	-1,809.64%-3.76M	-153.63%-982K	-53.27%2.51M	-73.60%1.11M	-118.03%-239K	94.59%-197K	-47.27%1.83M	859.35%5.36M	371.26%4.2M
-Change in receivables	-19.71%2.07M	63.30%-236K	6.87%-840K	-91.86%484K	-116.13%-543K	2,931.29%2.57M	41.38%-643K	-123.96%-902K	238.65%5.94M	729.25%3.37M
-Change in prepaid assets	84.52%286K	-80.12%-589K	65.78%-103K	-30,000.00%-299K	61.99%174K	5,766.77%155K	-276.97%-327K	-1,249.11%-301K	-98.86%1K	210.01%107.41K
-Change in payables and accrued expense	176.03%2.26M	-479.95%-2.94M	-101.52%-39K	416.27%1.85M	102.65%1.48M	-309.84%-2.97M	131.45%773K	1,049.48%2.56M	-119.15%-584K	-52.13%729.84K
-Change in other working capital	----	----	----	--473K	--0	--0	--0	--473K	----	----
Cash from discontinued investing activities
Operating cash flow	32.31%-5.18M	-37.31%-11.66M	-26.30%-7.32M	-14.63%-27.79M	-44.63%-5.85M	-8.50%-7.65M	11.94%-8.49M	-65.50%-5.79M	20.23%-24.24M	47.31%-4.04M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities	-49.46%4.55M	-60.31%7.28M	-77.13%59K	39.29%29.65M	83,341.56%2.06M	30.28%9M	54.90%18.33M	-89.84%258K	-86.11%21.29M	-99.89%2.46K
Net common stock issuance	-51.89%4.11M	----	----	32.83%27.88M	41,554.98%1.19M	29.65%8.53M	----	----	-86.30%20.99M	1,022.83%2.85K
Proceeds from stock option exercised by employees	-5.33%444K	-45.30%99K	-77.13%59K	75.84%1.78M	456,942.11%868K	-8.62%469K	46.65%181K	-30.92%258K	-81.88%1.01M	-100.01%-190
Net other financing activities	----	----	----	----	----	----	----	----	87.26%-707K	98.87%-198
Cash from discontinued financing activities
Financing cash flow	-49.46%4.55M	-60.31%7.28M	-77.13%59K	39.29%29.65M	83,341.56%2.06M	30.28%9M	54.90%18.33M	-89.84%258K	-86.11%21.29M	-99.89%2.46K
Net cash flow
Beginning cash position	-9.18%139.39M	0.10%143.77M	1.25%151.02M	-1.94%149.16M	1.06%154.82M	0.08%153.47M	-4.98%143.62M	-1.94%149.16M	420.05%152.11M	-2.77%153.2M
Current changes in cash	-146.67%-630K	-144.48%-4.38M	-31.12%-7.26M	163.25%1.87M	6.15%-3.79M	1,042.71%1.35M	348.27%9.85M	-475.83%-5.54M	-102.40%-2.95M	25.87%-4.04M
End cash Position	-10.37%138.76M	-9.18%139.39M	0.10%143.77M	1.25%151.02M	1.25%151.02M	1.06%154.82M	0.08%153.47M	-4.98%143.62M	-1.94%149.16M	-1.94%149.16M
Free cash flow	32.31%-5.18M	-37.31%-11.66M	-26.30%-7.32M	-14.63%-27.79M	-44.63%-5.85M	-8.50%-7.65M	11.94%-8.49M	-65.50%-5.79M	20.23%-24.24M	47.31%-4.04M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data